Birth of a healthy infant after bone marrow-derived cell therapy |
Patel, Nayana H
(Department of Reproductive Medicine, Akanksha Hospital and Research Institute)
Jadeja, Yuvraj D (Department of Reproductive Medicine, Akanksha Hospital and Research Institute) Patel, Niket H (Department of Reproductive Medicine, Akanksha Hospital and Research Institute) Patel, Molina N (Department of Reproductive Medicine, Akanksha Hospital and Research Institute) Bhadarka, Harsha K (Department of Reproductive Medicine, Akanksha Hospital and Research Institute) Chudasama, Piyush N (Department of Reproductive Medicine, Akanksha Hospital and Research Institute) Thakkar, Harmi R (Department of Reproductive Medicine, Akanksha Hospital and Research Institute) |
1 | Lee YJ, Yi KW. Bone marrow-derived stem cells contribute to regeneration of the endometrium. Clin Exp Reprod Med 2018;45:149-53. DOI |
2 | Santamaria X, Cabanillas S, Cervello I, Arbona C, Raga F, Ferro J, et al. Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study. Hum Reprod 2016;31:1087-96. DOI |
3 | Dreisler E, Kjer JJ. Asherman's syndrome: current perspectives on diagnosis and management. Int J Womens Health 2019;11:191-8. DOI |
4 | Gargett CE, Healy DL. Generating receptive endometrium in Asherman's syndrome. J Hum Reprod Sci 2011;4:49-52. |
5 | Singh N, Mohanty S, Seth T, Shankar M, Bhaskaran S, Dharmendra S. Autologous stem cell transplantation in refractory Asherman's syndrome: a novel cell based therapy. J Hum Reprod Sci 2014;7:93-8. DOI |
6 | Azizi R, Aghebati-Maleki L, Nouri M, Marofi F, Negargar S, Yousefi M. Stem cell therapy in Asherman syndrome and thin endometrium: stem cell- based therapy. Biomed Pharmacother 2018;102:333-43. DOI |
7 | Sakr S, Naqvi H, Komm B, Taylor HS. Endometriosis impairs bone marrow-derived stem cell recruitment to the uterus whereas bazedoxifene treatment leads to endometriosis regression and improved uterine stem cell engraftment. Endocrinology 2014;155:1489-97. DOI |
8 | Liu Y, Tal R, Pluchino N, Mamillapalli R, Taylor HS. Systemic administration of bone marrow-derived cells leads to better uterine engraftment than use of uterine-derived cells or local injection. J Cell Mol Med 2018;22:67-76. DOI |
9 | Cervello I, Gil-Sanchis C, Santamaria X, Cabanillas S, Diaz A, Faus A, et al. Human CD133(+) bone marrow-derived stem cells promote endometrial proliferation in a murine model of Asherman syndrome. Fertil Steril 2015;104:1552-60.e1-3. DOI |